Revenue and Earnings Beat Expectations
Agilent reported $1.74 billion in revenue for Q3, surpassing guidance, and achieved earnings per share of $1.37. The company has raised its fiscal 2025 full-year revenue guidance to $6.91 to $6.93 billion.
Continued Growth in Pharma and Chemicals Markets
Core revenue growth in pharma was 9%, driven by small molecule demand and adoption of the Infinity Tree LC platform. Chemicals and advanced materials grew 10%, supported by semiconductor and chemical sector investments.
Strong Geographic Performance
Broad-based growth was reported across all regions, with Asia ex-China growing 10% and EMEA showing a 7% increase. India showed exceptional growth at 20%.
Successful Cost Management and Innovation
The Ignite enterprise operating model delivered double-digit savings in key cost categories. Innovation drivers include the Infinity Tree LC platform, Pro IQ LCMS system, and DACO OMDAS family.